UNRESECTABLE/METASTATIC COLORECTAL CANCER
Clinical trials for UNRESECTABLE/METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE/METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE/METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo takes on tough colorectal cancer
Disease control Not yet recruitingThis early-stage trial tests a new drug called EMB-01, a bispecific antibody that targets two cancer-related proteins, combined with standard chemotherapy. About 120 adults with advanced colorectal cancer that cannot be surgically removed will receive the combination. The main go…
Matched conditions: UNRESECTABLE/METASTATIC COLORECTAL CANCER
Phase: PHASE1 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New chemo cocktail aims to slow advanced colon cancer
Disease control Not yet recruitingThis study tests a new chemotherapy regimen called FOLFOX8 against the standard mFOLFOX6, both combined with targeted drugs (bevacizumab or cetuximab), as a first treatment for people with metastatic colorectal cancer that cannot be surgically removed. About 229 participants will…
Matched conditions: UNRESECTABLE/METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC